De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!
Kangji Medical Holdings Beheer
Beheer criteriumcontroles 4/4
De CEO Kangji Medical Holdings' is Ming Zhong, benoemd in Aug2004, heeft een ambtstermijn van 20.17 jaar. De totale jaarlijkse vergoeding van { bedraagt CN¥ 1.23M, bestaande uit 96.2% salaris en 3.8% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 33.77% van de aandelen van het bedrijf, ter waarde HK$ 2.47B. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 3.8 jaar en 4.6 jaar.
Belangrijke informatie
Ming Zhong
Algemeen directeur
CN¥1.2m
Totale compensatie
| Percentage CEO-salaris | 96.2% |
| Dienstverband CEO | 20.2yrs |
| Eigendom CEO | 33.8% |
| Management gemiddelde ambtstermijn | 3.8yrs |
| Gemiddelde ambtstermijn bestuur | 4.6yrs |
Recente managementupdates
Recent updates
Investors Could Be Concerned With Kangji Medical Holdings' (HKG:9997) Returns On Capital
Apr 12
Kangji Medical Holdings Limited (HKG:9997) Shares Could Be 32% Above Their Intrinsic Value Estimate
Mar 08Kangji Medical Holdings Limited's (HKG:9997) Share Price Not Quite Adding Up
Dec 21Kangji Medical Holdings' (HKG:9997) Returns On Capital Not Reflecting Well On The Business
Oct 23Should You Be Adding Kangji Medical Holdings (HKG:9997) To Your Watchlist Today?
Aug 17A Look At The Intrinsic Value Of Kangji Medical Holdings Limited (HKG:9997)
Jul 28Kangji Medical Holdings (HKG:9997) Will Be Hoping To Turn Its Returns On Capital Around
May 16Is Now The Time To Put Kangji Medical Holdings (HKG:9997) On Your Watchlist?
May 01Some Shareholders Feeling Restless Over Kangji Medical Holdings Limited's (HKG:9997) P/E Ratio
Apr 13A Look At The Fair Value Of Kangji Medical Holdings Limited (HKG:9997)
Mar 28Here's Why Kangji Medical Holdings (HKG:9997) Has Caught The Eye Of Investors
Jan 03Are Kangji Medical Holdings Limited (HKG:9997) Investors Paying Above The Intrinsic Value?
Sep 21Kangji Medical Holdings (HKG:9997) Is Reinvesting At Lower Rates Of Return
Jun 12Kangji Medical Holdings' (HKG:9997) Shareholders Will Receive A Bigger Dividend Than Last Year
May 16Kangji Medical Holdings (HKG:9997) Will Pay A Larger Dividend Than Last Year At HK$0.17
May 02Returns On Capital At Kangji Medical Holdings (HKG:9997) Paint A Concerning Picture
Dec 20Analysts Just Slashed Their Kangji Medical Holdings Limited (HKG:9997) EPS Numbers
Mar 31Here's Why We Think Kangji Medical Holdings' (HKG:9997) Statutory Earnings Might Be Conservative
Feb 03
Does Kangji Medical Holdings Limited (HKG:9997) Create Value For Shareholders?
Dec 30An Intrinsic Calculation For Kangji Medical Holdings Limited (HKG:9997) Suggests It's 42% Undervalued
Nov 25Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | CN¥534m |
| Mar 31 2024 | n/a | n/a | CN¥519m |
| Dec 31 2023 | CN¥1m | CN¥1m | CN¥504m |
| Sep 30 2023 | n/a | n/a | CN¥540m |
| Jun 30 2023 | n/a | n/a | CN¥576m |
| Mar 31 2023 | n/a | n/a | CN¥528m |
| Dec 31 2022 | CN¥1m | CN¥1m | CN¥479m |
| Sep 30 2022 | n/a | n/a | CN¥447m |
| Jun 30 2022 | n/a | n/a | CN¥415m |
| Mar 31 2022 | n/a | n/a | CN¥436m |
| Dec 31 2021 | CN¥1m | CN¥990k | CN¥457m |
Compensatie versus markt: De totale vergoeding ($USD 175.53K ) Ming } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de Hong Kong markt ($USD 488.24K ).
Compensatie versus inkomsten: De vergoeding van Ming is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Ming Zhong (48 yo)
20.2yrs
Tenure
CN¥1,232,000
Compensatie
Mr. Ming Zhong serves as Executive Director of Kangji Medical Holdings Limited since March 7, 2020 and Chief Executive Officer since August 24, 2004 and is its Executive Chairman since May 2024. He is main...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman of the Board & CEO | 20.2yrs | CN¥1.23m | 33.77% CN¥ 2.5b | |
| Vice GM & Executive Director | 7.9yrs | CN¥1.03m | 19.14% CN¥ 1.4b | |
| Executive Director | less than a year | CN¥4.80m | geen gegevens | |
| Vice GM & Executive Director | 4.6yrs | CN¥1.94m | geen gegevens | |
| Chief Financial Officer | 1.1yrs | geen gegevens | geen gegevens | |
| Head of Domestic Sales & Marketing | 3.8yrs | geen gegevens | geen gegevens | |
| Company Secretary | 2.4yrs | geen gegevens | geen gegevens |
3.8yrs
Gemiddelde duur
45yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van 9997 wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.8 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Executive Chairman of the Board & CEO | 4.7yrs | CN¥1.23m | 33.77% CN¥ 2.5b | |
| Vice GM & Executive Director | 4.6yrs | CN¥1.03m | 19.14% CN¥ 1.4b | |
| Executive Director | less than a year | CN¥4.80m | geen gegevens | |
| Vice GM & Executive Director | 2.5yrs | CN¥1.94m | geen gegevens | |
| Independent Non-Executive Director | 4.6yrs | CN¥102.00k | geen gegevens | |
| Non-Executive Director | 4.6yrs | geen gegevens | geen gegevens | |
| Independent Non-Executive Director | 4.6yrs | CN¥102.00k | geen gegevens | |
| Independent Non-Executive Director | 4.6yrs | CN¥102.00k | geen gegevens |
4.6yrs
Gemiddelde duur
48yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van 9997 wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.6 jaar).